Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Chon · SciRah

Researcher profile · Semantic Scholar

H. Chon

Share profile

H. Chon — researcher profile on SciRah

h-index: 19
Works: 99
Citations: 1,347

Most-cited papers

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
S. Westin, K. Moore, H. Chon, Jung-Yun Lee +26 more
2023Journal of Clinical Oncology331 citations Open access
Semantic Scholar
A Phase III Study of Pafolacianine Injection (0TL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)
J. Tanyi, L. Randall, S. Chambers, K. Butler +10 more
2022Journal of Clinical Oncology129 citations
Semantic Scholar
BAD phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
D. Marchion, H. Cottrill, Y. Xiong, N. Chen +20 more
2011Clinical Cancer Research88 citations Open access
Semantic Scholar
Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers
C. Kunos, S. Andrews, K. Moore, H. Chon +1 more
2019Frontiers in Oncology54 citations Open access
Semantic Scholar
Targeted therapies in gynecologic cancers.
H. Chon, Wei Hu, J. Kavanagh
2006Current Cancer Drug Targets47 citations
Semantic Scholar
Microarray-based gene expression studies in ovarian cancer.
H. Chon, J. Lancaster
2011Cancer Control: Journal of the Moffitt Cancer Cente43 citations
Semantic Scholar
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival
E. Biçaku, Y. Xiong, D. Marchion, H. Chon +11 more
2012British Journal of Cancer41 citations Open access
Semantic Scholar
A Longitudinal Examination of Associations between Age and Chemotherapy-Induced Peripheral Neuropathy in Patients with Gynecologic Cancer
H. Bulls, A. Hoogland, B. Kennedy, B. James +6 more
2018Gynecologic Oncology38 citations Open access
Semantic Scholar
Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data.
J. Bosquet, D. Marchion, H. Chon, J. Lancaster +1 more
2014Cancer Research37 citations Open access
Semantic Scholar
Initial efficacy and safety results from ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC).
Susana Banerjee, K. Ring, E. Van Nieuwenhuysen, M. Fabbro +16 more
2023Journal of Clinical Oncology33 citations Open access
Semantic Scholar
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
L. Randall, D. O'Malley, B. Monk, Robert L. Coleman +17 more
2023Gynecologic Oncology28 citations
Semantic Scholar
High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.
A. Rishi, Madeline Rollins, K. Ahmed, D. Hunt +9 more
2019Gynecologic Oncology28 citations
Semantic Scholar
LONG-TERM FOLLOW-UP OF EFFICACY AND SAFETY OF SELINEXOR MAINTENANCE TREATMENT IN PATIENTS WITH TP53WT ADVANCED OR RECURRENT ENDOMETRIAL CANCER: A SUBGROUP ANALYSIS OF THE ENGOT-EN5/GOG-3055/SIENDO STUDY
V. Makker, J. Pérez-Fidalgo, G. Valabrega, Erika Hamilton +26 more
2024Gynecologic Oncology27 citations Open access
Semantic Scholar
Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity
P. Judson, E. al Sawah, D. Marchion, Y. Xiong +10 more
2012International Journal of Gynecologic Cancer27 citations Open access
Semantic Scholar
Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.
A. Mallen, S. Todd, S. Robertson, Jongphil Kim +4 more
2021Gynecologic Oncology26 citations
Semantic Scholar
Quality of life after pelvic exenteration for gynecologic cancer: Findings from a qualitative study
A. Nelson, Alexandra Albizu-Jacob, Alyssa Fenech, H. Chon +2 more
2018Psycho-Oncology26 citations
Semantic Scholar
The role of surgery in the management of epithelial ovarian cancer.
I. Ramirez, H. Chon, S. Apte
2011Cancer Control: Journal of the Moffitt Cancer Cente24 citations Open access
Semantic Scholar
The BCL2 Antagonist of Cell Death pathway influences endometrial cancer cell sensitivity to cisplatin
H. Chon, D. Marchion, Y. Xiong, N. Chen +9 more
2011Gynecologic Oncology23 citations Open access
Semantic Scholar
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance
Bernadette M. Boac, Y. Xiong, D. Marchion, F. Abbasi +14 more
2015Gynecologic Oncology22 citations Open access
Semantic Scholar
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
N. Chen, H. Chon, Y. Xiong, D. Marchion +9 more
2013Oncology Report19 citations Open access
Semantic Scholar
Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer.
J. Tanyi, H. Chon, M. Morgan, S. Chambers +7 more
202117 citations
Semantic Scholar
Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy
H. Mohammadi, A. Prince, N. Figura, Jeffrey S. Peacock +7 more
2019International Journal of Radiation Oncology, Biology, Physics17 citations Open access
Semantic Scholar
Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers
H. Chon, Sokbom Kang, Jae K. Lee, S. Apte +3 more
2017BMC Cancer16 citations Open access
Semantic Scholar
Major vascular injury during gynecologic cancer surgery
A. Buras, J. Chern, H. Chon, M. Shahzad +2 more
2021Gynecologic Oncology Reports13 citations Open access
Semantic Scholar
The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer
N. Zgheib, Y. Xiong, D. Marchion, E. Biçaku +11 more
2012International Journal of Oncology13 citations Open access
Semantic Scholar
MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib + dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC).
L. Randall, D. O'Malley, B. Monk, R. Coleman +16 more
2022Journal of Clinical Oncology11 citations
Semantic Scholar
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.
E. al Sawah, Xin Chen, D. Marchion, Y. Xiong +8 more
2013Gynecologic Oncology11 citations
Semantic Scholar
Cumulative Burden of Symptomatology in Patients with Gynecologic Malignancies Undergoing Chemotherapy
L. Oswald, S. Eisel, D. Tometich, Crystal A. Bryant +7 more
2022Health Psychology10 citations Open access
Semantic Scholar
Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy
A. Prince, H. Mohammadi, D. Fernandez, M. Montejo +5 more
2019International Journal of Radiation Oncology, Biology, Physics10 citations Open access
Semantic Scholar
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.
Stephen H. Bush, Sharon Tollin, D. Marchion, Y. Xiong +12 more
2016Molecular and clinical oncology10 citations Open access
Semantic Scholar
Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer
D. Marchion, Y. Xiong, H. Chon, E. al Sawah +11 more
2013American Journal of Obstetrics and Gynecology10 citations Open access
Semantic Scholar
Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.
C. Leath, W. Deng, L. Mell, D. Richardson +16 more
2023Journal of Clinical Oncology9 citations
Semantic Scholar
Phase 2 trial of tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208).
H. Mahdi, S. Schuster, D. O'Malley, D. McNamara +5 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix
R. Abdallah, Stephen H. Bush, H. Chon, S. Apte +2 more
2015International Journal of Gynecologic Cancer9 citations Open access
Semantic Scholar
Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data
R. Abdallah, H. Chon, N. Zgheib, D. Marchion +3 more
2015International Journal of Gynecologic Cancer8 citations Open access
Semantic Scholar
The impact of distance to closest negative margin on survival after pelvic exenteration.
Alexandra L. Martin, S. Sinha, L. Peres, A. Hakam +5 more
2022Gynecologic Oncology7 citations
Semantic Scholar
Ovarian microcystic stromal tumor: Radiologic-pathologic correlation
D. Jeong, A. Hakam, Mohammad Abuel-Haija, H. Chon
2018Gynecologic Oncology Reports7 citations Open access
Semantic Scholar
Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
D. Tometich, A. Hoogland, B. Small, M. Janelsins +18 more
2023Cancers6 citations Open access
Semantic Scholar
Comparison of Definitive Cervical Cancer Management With Chemotherapy and Radiation Between Two Centers With Variable Resources and Opportunities for Improved Treatment
F. Asamoah, J. Yarney, A. Scott, V. Vanderpuye +13 more
2020JCO Global Oncology6 citations Open access
Semantic Scholar
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer
Bernadette M. Boac, Y. Xiong, S. Apte, R. Wenham +4 more
2018American Journal of Obstetrics and Gynecology6 citations
Semantic Scholar
Update on Aurora Kinase Targeted Therapeutics in Oncology
Xia Tao, H. Chon, S. Fu, J. Kavanagh +1 more
2008Recent Patents on Anti-Cancer Drug Discovery6 citations Open access
Semantic Scholar
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.
R. Wenham, A. Buras, Sarah W. Gordon, J. Whiting +9 more
2025International Journal of Gynecological Cancer5 citations
Semantic Scholar
Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study
K. Ahmed, A. Quick, H. Chon, J. Chern +13 more
2025International Journal of Radiation Oncology, Biology, Physics5 citations
Semantic Scholar
A Randomized Phase 3 Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor Positive Ovarian Cancer
J. Tanyi, L. Randall, S. Chambers, K. Butler +10 more
2021Social Science Research Network5 citations Open access
Semantic Scholar
SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer.
I. Vergote, J. Pérez-Fidalgo, E. Hamilton, T. van Gorp +16 more
20214 citations
Semantic Scholar
Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer (EC) in DUO-E: Results by BRCA1/BRCA2 mutation (BRCAm) status.
E. Van Nieuwenhuysen, J. Baurain, H. Chon, J. Thomes Pepin +16 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study
K. Ahmed, A. Quick, K. Bixel, Y. Kim +10 more
2022International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
Specimen extraction techniques utilized in minimally invasive surgery for uterine cancer and an enlarged uterus: a quality assurance study
A. Quian, A. Mercier, Clarissa Lam, R. Wenham +5 more
2025Journal of Robotic Surgery2 citations
Semantic Scholar
Post-traumatic reactions and quality of life after pelvic exenteration for gynecologic cancer: a retrospective cohort study
Lora M. A. Thompson, Nele Loecher, Alexandra Albizu-Jacob, H. Chon +2 more
2024Supportive Care in Cancer2 citations Open access
Semantic Scholar
Prognostic features of endometrial cancer metastasis to the central nervous system
M. Kuznicki, A. Mallen, Kristal Ha, E. McClung +9 more
2022PLoS ONE2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Wenham×32
Invite
R. Wenham — researcher profile on SciRah
S. Apte×19
Invite
S. Apte — researcher profile on SciRah
J. Lancaster×13
Invite
J. Lancaster — researcher profile on SciRah
D. Marchion×12
Invite
D. Marchion — researcher profile on SciRah

×11

Invite

Y. Xiong — researcher profile on SciRah

Invite

M. Shahzad — researcher profile on SciRah

Invite

A. Hakam — researcher profile on SciRah

Invite

P. Judson — researcher profile on SciRah

J. Gonzalez-Bosquet×8

Invite

J. Gonzalez-Bosquet — researcher profile on SciRah

Invite

J. Chern — researcher profile on SciRah

Invite

X. Stickles — researcher profile on SciRah

Invite

N. Zgheib — researcher profile on SciRah